Evidence map›Paper›PMID 42525183›Full record

ArticleMolecular biology reports2026

Improvement of soluble expression of anti-PD-1/CTLA-4 diabody in the cytoplasm of Escherichia coli.

Mohammad Mehdi Khaleghi, Parisa Sadreameli, Kourosh Eslami, Vajihe Akbari

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammad Mehdi Khaleghi *Pharmacy Student Research Committee, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
Parisa Sadreameli *Pharmacy Student Research Committee, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
Kourosh EslamiPharmacy Student Research Committee, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
Vajihe AkbariDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran. v_akbari@pharm.mui.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli is one of the most efficient and widely used expression systems for the production of biopharmaceuticals. Despite all its many advantages, E. coli cannot efficiently produce complex, high molecular weight proteins produce complexmonoclonal antibodies and diabodies. In this study, the cytoplasmic soluble expression of a previously designed anti-PD-1/CTLA-4 single chain diabody (scDb) was evaluated at different incubation temperatures (15, 23, 30, and 37 °C) and IPTG concentrations (0.1, 0.5, and 1 mM) in E. coli BL21(DE3), Origami B(DE3), and SHuffle T7 strains. The effect of co-expression of the DnaK, DnaJ and GrpE chaperone on soluble protein expression was also investigated in E. coli BL21(DE3). The results showed that E. coli SHuffle T7 produced the highest expression of soluble protein. Lower incubation temperature increased the yield of soluble protein in all strains, whereas IPTG concentration had a negligible effect. Co-expression of chaperones in the E. coli BL21(DE3) also improved protein solubility compared with expression of the scDb alone. These findings suggest that E. coli SHuffle T7 is a promising host for the production of recombinant proteins production. In addition, chaperone co-expression and reduced incubation temperature can be considered effective strategies for higher soluble protein production.

Indexed as

CTLA-4 AntigenEscherichia coliProgrammed Cell Death 1 ReceptorSingle-Chain AntibodiesCytoplasmEscherichia coli ProteinsMolecular ChaperonesRecombinant ProteinsSolubilityTemperatureCTLA-4 AntigenEscherichia coli ProteinsMolecular ChaperonesProgrammed Cell Death 1 ReceptorRecombinant ProteinsSingle-Chain AntibodiesCo‑expressionDnaK/DnaJ/GrpEMolecular chaperoneShuffle T7Single chain diabodyTemperature

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.